Showing results (171-180 of 281) with videos related to

Sort By:
Pageof 29
Bioorganic & Medicinal Chemistry Letters|November 26, 2005
Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgammaEsther Y H Chao, Jon L Collins, Stéphanie Gaillard, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Linking the kinetic mechanism to structural dynamics required for nucleotide hydrolysis by an alphavirus nsP2 RNA helicaseKacey M Talbot, Yuan-Wei Norman Su, Jake B Royster, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weightK G Liu, M H Lambert, A H Ayscue, et al.
The Journal of Biological Chemistry|May 29, 2000
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposityM Guerre-Millo, P Gervois, E Raspé, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2008
Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitmentCaroline A Phelan, Joseph M Weaver, David J Steger, et al.
Infection Control and Hospital Epidemiology|May 24, 2024
Development and implementation of a nationwide multidrug-resistant organism tracking and alert system for Veterans Affairs medical centersChristopher D Pfeiffer, Makoto M Jones, James S Klutts, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaS A Kliewer, S S Sundseth, S A Jones, et al.
Journal of Medicinal Chemistry|April 29, 2005
Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgammaWilliam J Zuercher, Stéphanie Gaillard, Lisa A Orband-Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivoAndrew E Place, Nanjoo Suh, Charlotte R Williams, et al.
Endocrinology|September 1, 1997
Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in boneT M Willson, J D Norris, B L Wagner, et al.
Pageof 29